R&G PharmaStudies Co. Ltd. A Tangible Net Worth Ratio
R&G PharmaStudies Co. Ltd. A tangible net worth ratio. R&G PharmaStudies Co. Ltd. A (301333) has a Tangible Net Worth Ratio of 99.2% as of March 2026. This metric is calculated by deducting intangible assets (CN¥15.35 Million) from net assets (CN¥2.00 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See R&G PharmaStudies Co. Ltd. A balance sheet quality to measure how much of total assets are equity-financed.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of R&G PharmaStudies Co. Ltd. A (2019–2025)
Tangible net worth ratio of R&G PharmaStudies Co. Ltd. A from 2019 to 2025. This chart shows how R&G PharmaStudies Co. Ltd. A's Tangible Net Worth Ratio has changed across 7 annual periods from 2019 to 2025. As of March 2026, the ratio stands at 99.2%, reflecting net assets of CN¥2.00 Billion with intangible assets of CN¥15.35 Million CNY. See R&G PharmaStudies Co. Ltd. A (301333) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
R&G PharmaStudies Co. Ltd. A Tangible Net Worth Ratio by Year (2019–2025)
R&G PharmaStudies Co. Ltd. A tangible net worth ratio by year from 2019 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for R&G PharmaStudies Co. Ltd. A from 2019 to 2025, covering 7 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see 301333 company net worth.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 99.2% | CN¥1.98 Billion | CN¥16.25 Million | CN¥2.40 Billion | ▲ +0.2 pp |
| 2024 | 98.9% | CN¥1.84 Billion | CN¥19.43 Million | CN¥2.34 Billion | ▼ 0.0 pp |
| 2023 | 99.0% | CN¥1.75 Billion | CN¥17.93 Million | CN¥2.07 Billion | ▼ -0.2 pp |
| 2022 | 99.2% | CN¥1.59 Billion | CN¥12.83 Million | CN¥1.88 Billion | ▲ +3.3 pp |
| 2021 | 95.9% | CN¥437.81 Million | CN¥17.88 Million | CN¥677.47 Million | ▲ +2.7 pp |
| 2020 | 93.2% | CN¥336.98 Million | CN¥22.96 Million | CN¥536.36 Million | ▲ +0.5 pp |
| 2019 | 92.7% | CN¥249.74 Million | CN¥18.16 Million | CN¥446.86 Million | — |